(Q37434212)

20 August 2017

title

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer (English)

1 reference

20 August 2017

0 references

1 reference

1 reference

3

Pasi A Jänne

1 reference

20 August 2017

Jason H Smouse

1

1 reference

20 August 2017

Edmund S Cibas

2

1 reference

20 August 2017

Victoria A Joshi

4

1 reference

20 August 2017

Kelly H Zou

5

1 reference

20 August 2017

Neal I Lindeman

6

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

117

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

67-72

1 reference

Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

The ErbB receptors and their role in cancer progression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20011

7 January 2021

Identifiers

DOI

10.1002/CNCY.20011

1 reference

release_k5vi3slb4ffdxjsk2jy6kmp53a

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k5vi3slb4ffdxjsk2jy6kmp53a

24 November 2022

mapped directly with Wikidata item

1 reference